Projects funded by the NCN
Integrity of E3 ubiquitin ligase complex as a biomarker of response to treatment with immunomodulatory drugs in patients with multiple myeloma.
2014/13/B/NZ5/03160
Keywords:
cereblone thalidomide lenalidomide multiple myeloma
Descriptors:
- NZ5_3: Pathogenesis of human diseases
- NZ5_7: Human disease treatment
- NZ5_9: Other related subjects
Panel:
NZ5 - Human and animal noninfectious diseases: etiology, mechanisms, diagnosis and treatment of diseases, poisonings and injuries (without neurological diseases)
Host institution :
Instytut Hematologii i Transfuzjologii
woj. mazowieckie
Principal investigator (from the host institution):
Number of co-investigators in the project: 5
Call: OPUS 7 - announced on 2014-03-17
Amount awarded: 403 084 PLN
Project start date (Y-m-d): 2015-02-25
Project end date (Y-m-d): 2018-02-24
Project duration:: 36 months (the same as in the proposal)
Project status: Project settled